Glenmark Pharmaceuticals to launch Eribulin Mesylate Injection, 1mg/2Ml (0.5 mg/mL) single-dose vials Read more
Glenmark USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials Read more
Glenmark announces launch of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) multiple-dose vial Read more